Ballentine Partners LLC Increases Stake in Sabra Healthcare REIT, Inc. $SBRA

Ballentine Partners LLC grew its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 8.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,568 shares of the real estate investment trust’s stock after buying an additional 1,090 shares during the quarter. Ballentine Partners LLC’s holdings in Sabra Healthcare REIT were worth $250,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in SBRA. Bank of New York Mellon Corp boosted its stake in shares of Sabra Healthcare REIT by 1.8% in the first quarter. Bank of New York Mellon Corp now owns 4,114,215 shares of the real estate investment trust’s stock worth $71,875,000 after acquiring an additional 74,564 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Sabra Healthcare REIT in the first quarter worth approximately $61,791,000. Advisors Capital Management LLC boosted its stake in shares of Sabra Healthcare REIT by 20.5% in the first quarter. Advisors Capital Management LLC now owns 2,232,609 shares of the real estate investment trust’s stock worth $39,004,000 after acquiring an additional 380,505 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Sabra Healthcare REIT by 16.8% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,687,977 shares of the real estate investment trust’s stock worth $29,489,000 after acquiring an additional 243,274 shares during the last quarter. Finally, Victory Capital Management Inc. boosted its stake in shares of Sabra Healthcare REIT by 12.7% in the first quarter. Victory Capital Management Inc. now owns 1,630,076 shares of the real estate investment trust’s stock worth $28,477,000 after acquiring an additional 183,739 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Performance

Shares of Sabra Healthcare REIT stock opened at $18.58 on Tuesday. Sabra Healthcare REIT, Inc. has a 52 week low of $15.60 and a 52 week high of $20.03. The business’s fifty day simple moving average is $18.77 and its 200-day simple moving average is $18.14. The firm has a market cap of $4.46 billion, a PE ratio of 24.45, a price-to-earnings-growth ratio of 1.50 and a beta of 0.88. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. During the same quarter in the prior year, the company posted $0.36 EPS. The company’s quarterly revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.5%. The ex-dividend date was Friday, August 15th. Sabra Healthcare REIT’s payout ratio is currently 157.89%.

Wall Street Analysts Forecast Growth

SBRA has been the topic of a number of research analyst reports. Wells Fargo & Company lifted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 27th. JMP Securities boosted their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a research note on Wednesday, August 6th. BMO Capital Markets boosted their price objective on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a research note on Monday, August 25th. Scotiabank boosted their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a research note on Monday, June 23rd. Finally, Truist Financial boosted their price objective on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a research note on Tuesday, September 2nd. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $20.83.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.